Therapeutic Neuromodulation Systems files Form D for $5 million equity offering
The Louisiana biotechnology company reported $1,709,500 sold toward the offering as of a filing signed September 21, 2026.
Therapeutic Neuromodulation Systems LLC, a Louisiana-based company, filed a Form D notice of exempt securities offering with the Securities and Exchange Commission. The company is organized as a Limited Liability Company in Louisiana and was formed over five years ago.1 Its principal place of business is listed at 4405 N I-10 Service W Suite 100 in Metairie, Louisiana.1
The company classified its industry as Biotechnology within the Health Care sector.1 The filing marks a new notice, with the date of first sale listed as October 15, 2017.1 The offering is being made under Rule 506(b) of Regulation D.1
The total offering amount is set at $5,000,000, with $1,709,500 sold and $3,290,500 remaining to be sold.1 The minimum investment accepted from any outside investor is $5,000.1 The filing indicates that securities may be sold to non-accredited investors, listing 6 such investors among a total of 29 investors who have already invested in the offering.1
The company reported $0 in sales commissions and $0 in finders' fees.1 It estimated $350,000 in gross proceeds used for payments to executive officers, directors, or promoters named in the filing.1
Arnold Joseph Rougee of New Orleans, Louisiana is listed as an executive officer and manager of the company.1 Rougee signed the filing on behalf of the issuer on September 21, 2026, in his capacity as Manager.1 The company does not intend for the offering to last more than one year.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.